Display options
Cite
Abu-Shawer O, Bushnaq T, Abu-Shawer M. Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents. Gulf J Oncolog. 2019;1(29):76-82
Abu-Shawer, O., Bushnaq, T., & Abu-Shawer, M. (2019). Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents. The Gulf journal of oncology, 1(29), 76-82.
Abu-Shawer, Osama, et al. "Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents." The Gulf journal of oncology vol. 1,29 (2019): 76-82.
Abu-Shawer O, Bushnaq T, Abu-Shawer M. Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents. Gulf J Oncolog. 2019 Jan;1(29):76-82. PMID: 30956199.
Copy Download .nbib Format: NLM
Share it on

Gulf J Oncolog. 2019 Jan;1(29):76-82.

Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents.

The Gulf journal of oncology

Osama Abu-Shawer, Tariq Bushnaq, Mohammad Abu-Shawer

Affiliations

  1. School of Medicine University of Jordan, Amman, Jordan.
  2. Clinical Research Office King Hussein Cancer Center, Amman, Jordan.

PMID: 30956199

Abstract

After several years of discouraging results, immunotherapy finally becomes a powerful, clinically valid and approved treatment for numerous types of cancer. Immunotherapy involves treatment approaches that work in various ways; some boost the body's immune system while others help guide and direct the immune cells to attack cancer cells specifically. In this review article, we summarize the current cancer immunotherapy strategies; immune checkpoint blockade, adoptive cellular therapy, cancer vaccines, oncolytic viruses, and the monoclonal antibodies and discuss the recent progress and future trends of the combination therapies.

MeSH terms

Publication Types